VREX Key Statistics, Chart & Performance
The current stock price of VREX is 12.65 USD. In the past month the price increased by 9.24%. In the past year, price decreased by -5.39%.
VREX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.61 | 222.19B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.86 | 210.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.15 | 144.97B | ||
| SYK | STRYKER CORP | 27.82 | 140.11B | ||
| BDX | BECTON DICKINSON AND CO | 14.24 | 58.61B | ||
| IDXX | IDEXX LABORATORIES INC | 56.05 | 56.44B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.4 | 49.82B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.9 | 39.51B | ||
| RMD | RESMED INC | 25.17 | 36.37B | ||
| DXCM | DEXCOM INC | 37.58 | 27.26B | ||
| PODD | INSULET CORP | 64.41 | 20.71B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.71 | 18.78B |
Related stock screener links
About VREX
Company Profile
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
Company Info
VAREX IMAGING CORP
1678 S Pioneer Rd
Salt Lake City UTAH 84104 US
CEO: Sunny S. Sanyal
Employees: 2400
Phone: 18019725000
VAREX IMAGING CORP / VREX FAQ
What does VREX do?
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
What is the stock price of VAREX IMAGING CORP today?
The current stock price of VREX is 12.65 USD. The price increased by 2.76% in the last trading session.
Does VREX stock pay dividends?
VREX does not pay a dividend.
What is the ChartMill technical and fundamental rating of VREX stock?
VREX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is VREX stock listed?
VREX stock is listed on the Nasdaq exchange.
When does VAREX IMAGING CORP (VREX) report earnings?
VAREX IMAGING CORP (VREX) will report earnings on 2026-02-04.
VREX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VREX. When comparing the yearly performance of all stocks, VREX turns out to be only a medium performer in the overall market: it outperformed 53.54% of all stocks.
VREX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VREX. VREX has only an average score on both its financial health and profitability.
VREX Financial Highlights
Over the last trailing twelve months VREX reported a non-GAAP Earnings per Share(EPS) of 0.88. The EPS increased by 60% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| Debt/Equity | 0.79 |
VREX Forecast & Estimates
11 analysts have analysed VREX and the average price target is 17.54 USD. This implies a price increase of 38.69% is expected in the next year compared to the current price of 12.65.
For the next year, analysts expect an EPS growth of -0.32% and a revenue growth 3.92% for VREX